Drugs / colloidal bismuth tartrate
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05455372 | Jul 2022 → Sep 2023 | Helicobacter pylori infectious disease | Second Affiliated Hospital of Xi'an Jiaotong University | Unknown | No outcome recorded |
| — | NCT05226819 | Feb → Sep 2022 | Helicobacter pylori infectious disease | Second Affiliated Hospital of Xi'an Jiaotong University | Unknown | No outcome recorded |
| — | NCT05097846 | Jun 2021 → Jun 2022 | Helicobacter pylori infectious disease | wang xiaoyan | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT06168214 Comparator | Sep 2023 → Nov 2024 overdue | — | Xijing Hospital of Digestive Diseases | Recruiting | No outcome recorded |
| Phase 4 | NCT05237115 Comparator | May → Dec 2020 | dyspepsia, gastritis, peptic ulcer disease | Xijing Hospital of Digestive Diseases | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06250634 Comparator | Feb → May 2024 | Helicobacter pylori infectious disease | The Third Xiangya Hospital of Central South University | Completed | No outcome recorded |
| — | NCT05191875 Background | Dec 2021 → Apr 2022 | Helicobacter pylori infectious disease | The Third Xiangya Hospital of Central South University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | colloidal bismuth tartrate | “given for 14 days at a dose of colloidal bismuth tartrate capsule 55 mg 4 capsules BID, esomeprazole 40 mg BID, amoxicillin 500 mg 2 capsules BID, and clarithromycin 500 mg 1...” NCT05237115 ↗6“PPI quadruple therapy refers to ilaprazole 5mg + amoxicillin 1000mg + clarithromycin 500mg + colloidal bismuth tartrate 220mg bid.” NCT05455372 ↗ “colloidal bismuth tartrate 220mg bid” NCT06168214 ↗ |